17.9 C
New York
Wednesday, June 3, 2026

Tag: Anna

newssourceFORcompanyinformationcontent1marketreleases

New Research Funding Will Help to Strengthen Canada’s National School Food Program

Applications will be accepted until October 23 OTTAWA, ON, Aug. 5, 2025 /CNW/ - Employment and Social Development Canada (ESDC) and the Canadian Institutes of...

Interparfums, Inc. Reports 2025 Second Quarter and Half Year Results

Reaffirms 2025 Sales and Earnings Guidance 
Reaffirms 2025 Sales and Earnings Guidance

WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start Accounting adoption in connection with the emergence from its financial reorganization process on June 24, 2025. The earnings release and call was originally scheduled before the market opened on Tuesday, August 5, 2025.

Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction

www.freyapharmasolutions.com

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“ImageneBio”), a clinical stage biotechnology company dedicated to developing treatments for immunological/autoimmune and inflammatory (“I&I”) diseases, granted equity awards to Dr. Kristin Yarema, ImageneBio’s recently appointed Chief Executive Officer, on July 28, 2025 that were recommended by the Compensation Committee of its Board of Directors (the “Board”) and approved by the Board. The grant included (i) inducement stock options to purchase 436,080 shares of common stock; and (ii) inducement restricted stock units (“RSUs”) for 153,505 shares of common stock (together, the “Inducement Awards”). The Inducement Awards were granted as inducements material to Dr. Yarema entering into employment with ImageneBio in accordance with Nasdaq Listing Rule 5635(c)(4).

Total voting rights

LEI: 213800NNT42FFIZB1T09
01 August 2025

LAIKA Joins the Academy Software Foundation as a Premier Member

LOS ANGELES, July 31, 2025 /PRNewswire/ -- Today the Academy Software Foundation (ASWF) officially welcomes LAIKA as a Premier Member. Based in Portland, Oregon,...

Natural Gas Services Group, Inc. Initiates First Quarterly Dividend

Announces 2025 Second Quarter Earnings Release and Conference Call Schedule 
Announces 2025 Second Quarter Earnings Release and Conference Call Schedule

Subtle Medical Among First to Achieve ISO/IEC 42001:2023 Certification for AI Management

The certification reinforces the company's leadership in AI safety, efficacy, and ethical governance. MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- Subtle Medical, a global...

Dedola Global Logistics Unveils First Brand Update In Over Two Decades

A New Look That Reflects 50 Years of Precision, Innovation, and Personal Service LONG BEACH, Calif., July 29, 2025 /PRNewswire/ -- Dedola Global Logistics today...

HF Foods to Report Second Quarter 2025 Results on August 11, 2025

Company to Host Conference Call with Prepared Remarks and Q&A at 1:30 p.m. PT 
Company to Host Conference Call with Prepared Remarks and Q&A at 1:30 p.m. PT

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025

Interparfums, Inc. Reports 2025 Second Quarter Net Sales

2025 Second Quarter Conference Call Scheduled for August 6, 2025 
2025 Second Quarter Conference Call Scheduled for August 6, 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAnna

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers